Basilea Pharmaceutica International Ltd, Allschwil: Basilea announces start of first-in-human study of novel antibiotic BAL2420

AI Briefing

• – Basilea starts human trial of new antibiotic BAL2420
• – First-in-human study begins for novel antibiotic BAL2420
• – Basilea Pharmaceutica starts clinical trial of BAL2420